This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Click here for ReFacto AF® (moroctocog alfa) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.

Dosing that’s as individual as your patients 1–3

No two days are the same. No two patients are the same. ReFacto AF offers frequent, flexible dosing so your patients are covered for everyday life. 1–3
​​​​​​​

Patients may vary in their response to factor VIII, demonstrating different half-lives and recoveries1,2

Shorter dose intervals or higher doses may be necessary to deliver adequate coverage based on patient’s bleeding phenotype, levels of physical activity, and preference regarding convenience and adherence1–3

ReFacto AF offers frequent, flexible dosing1​​​​​​​

ReFacto AF comes in a range of vial sizes, so you can individualise factor VIII coverage for your patients.1​​​​​​​

ReFacto AF can be given as on-demand treatment or as prophylaxis1

So your patients are covered for everyday life1-3​​​​​​​

Explore more

Find out about how ReFacto AF is administered and reconstituted

Click here

Find out about ReFacto AF dosing for on-demand treatment and prophylaxis

Click here
References
  1. ReFacto AF (moroctocog alfa) Summary of Product Characteristics: https://www.medicines.org.uk/emc/product/6558/smpc
  2. Shapiro AD et al. Use of pharmacokinetics in the coagulation factor treatment of patients with haemophilia. Haemophilia 2005;11:571–582.
  3. Berntorp E, Andersson NG. Prophylaxis for hemophilia in the era of extended half-life factor VIII/factor IX products. Semin Thromb Hemost 2016;42:518–525.
PP-REF-GBR-0199. March 2021

Contact Pfizer

Speak to a member of the Pfizer Haemophilia team.

Click here

Find out about ReFacto AF efficacy 

Click here

Educational materials for children with haemophilia

Find out more

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No